Location & dates EMBL Heidelberg, Germany 14 - 17 Jun 2015
Deadlines Registration closed Abstract submission closed
EES_logo

Coronavirus information for participants

The onsite course and conference programme at EMBL has been paused until the end of June 2020.


We aim to continue offering our advanced training for the scientific community however we safely can. While some events have been cancelled, many have been rescheduled for a later date and others will be delivered as virtual events.


Registration is open for onsite courses and conferences starting after 1 July and for the virtual events. All registration fees for any events which don’t take place due to the COVID-19 disruption are fully refundable.


More information for participants of events at EMBL Heidelberg can be found here.

Latest News

  • Registration was closed on 3 May 2015. If you are interested to atend, please email Diah Yulianti
  • Do you have something to tweet? Use this hashtag: #EESNeuro

Why attend?

Neurodegenerative diseases represent a major challenge for today’s society in terms of the large and rapidly increasing number of the people that are afflicted and the general lack of effective treatments. The emphasis of this symposium will be on the genetic, cellular and molecular basis of neurodegenerative diseases including Alzheimer’s, Parkinson’s, Huntington’s, Amyotrophic Lateral Sclerosis and Prion disease. The meeting will cover the major mechanisms linked to neurodegeneration and highlight the similarities and differences between the diseases. A strong emphasis will be placed on the development of targeted drug therapies and potential treatment options. 

Aims

This symposium will bring together basic and clinical research scientists working on different forms of neurodegeneration with their counterparts from the biotechnology and pharma industry, to apply recent insights gained in the mechanisms of neurodegenerative diseases and the development of drug therapies. It will bridge the gap between basic research and medical research in an area that urgently requires therapeutic progress.

Topics

  • Mechanisms of neuronal and cognitive dysfunction
  • RNA, RNA binding proteins and RNA translation
  • Chaperones, autophagy and mitochondria
  • Disease progression
  • Novel therapeutic approaches
  • Translating to the clinic